Published: 2019 April 09
Updated : 2023 March 21

Pharmaceutical Mass Flow Controller Market Trends, Demand, Volume and Market Forecast 2023-2030

SKU : PH276
180 pages
Report Summary

Pharmaceutical Mass Flow Controller Market is segmented By Product (Thermal Flow Meter, Differential Pressure Flow Meter, Coriolis Mass Flow Meter,)By Fluid(Liquid, Gas, Solid) By Material(Exotic Alloys, Stainless Steel, Others) ), and Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030


Pharmaceutical Mass Flow Controller Market Overview

Pharmaceutical Mass Flow Controller Market size was valued at USD 163.4 million in 2022 and is estimated to reach at a compound annual growth rate (CAGR) of 6.40% over the forecast period 2023-2030. Owing to the growing demand for low flow rate controlling devices for precise measurements. Increasing developments in the laboratory & biomedical research sector that requires gas flow measurement under controlled conditions are expected to drive the mass flow controller market growth over the forecast period. The pharmaceutical mass flow controller market is multiplying due to the rising need for reliable and efficient measurement of liquid and gas flow. The pharmaceutical industry faces many challenges during the production of various products.

Pharmaceutical Mass Flow Controller Market Summary and Scope



Market CAGR


Segments Covered

 By Product, By Fluid, By Material, and By Region

Report Insights Covered

Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights.

Fastest Growing Region

Asia Pacific

Largest Market Share 

North America


To Get a Free Sample Click here


By using mass flow controllers, pharmaceutical companies have improved the accuracy and reliability of airflow measurement; improved the performance of the air handling units; and reduced installation and maintenance costs. As the medical & Pharmaceutical market is growing due to the growing aging population, the mass flow controller for the pharmaceutical industry is expected to grow with more opportunities.

Current and Post-COVID-19 growth prospects in pharmaceuticals and healthcare industries are the major factors driving the growth of the pharmaceuticals mass flow controller market. Mass flow controllers play a crucial role in the quality control of different types of medical devices, and several major companies have grabbed the opportunity to fight against the deadly coronavirus pandemic. For instance, RedySmart mass flow controllers of Sierra Instruments provide critical gas flow control systems for bioreactors to scale vaccines from lab to pilot to full-scale production.

Pharmaceutical Mass Flow Controller Market Dynamics

The mass flow controller (MFC) is commonly used in many bioprocessing systems to manage the flow of different gases into bioreactor chambers. Intelligent MFC technology with digital-based flow-control capabilities can help deliver more precise and versatile gas flow control, more sophisticated analysis, and resolution of process issues, and can also help equip bioprocess scientists and engineers with data that could lead to improved bioreactor performance. It plays an essential role in maintaining a bioreactor’s-controlled environment and achieving optimal cell growth.

Two critical factors that govern cell culture yield are the levels of dissolved oxygen (DO) in the bioreactor and the pH of the fermentation broth. For bioprocessing engineers, who focus on optimizing performance, controlling costs, and satisfying strict regulatory requirements MFCs provide a key tool for managing specific bioreactors as well as overall bioprocessing system performance, reducing unscheduled downtime, and maximizing integrity tester and bioreactor uptime and yields. The mass flow controller (MFC) has the application of bioreactors, including fermenters, which are for the production of bioethanol and other biofuels, pharmaceutical products, fine chemical products, food and beverages, and tissue growth. As dosing of Air, N2, O2, and CO2 into microbial and cell cultivation is critical.

Pharmaceutical Mass Flow Controller Market Segmentation Analysis

By Product

Based on product type pharmaceutical mass flow controller market is segmented by Thermal Flow Meter, Differential Pressure Flow Meter, Coriolis Mass Flow Meter, and others. As the temperature probes need only a very small cross-section, their impact on gas flow is minimal. Thus, one of the biggest advantages of the thermal mass flow meter is that it imposes negligible pressure drop.  As the pharmaceutical industry uses a lot of gas, thermal mass flow meters are preferred over other meters for gas flow measurement. Thermal mass flow meters have several advantages such as:

Maximize Product Consistency: Airflow transports the coating to the pills or tablets in tablet and coating processes. Drift or fluctuations in airflow will alter coating thickness and leave it uneven. To avoid this, the flow meter must not only be accurate but also respond quickly to minimize deviations.

Track Gas Usage: Most manufacturers that use gases like nitrogen, carbon dioxide, and oxygen will want to track consumption. Sub-metering allows monitoring down to the individual room, line, or even machine level and identifies any abnormal usage trends indicative of leaks or process problems.

Reduce Waste: In the pharmaceutical industry, variation leads to waste. By identifying and then reducing variation, engineers can improve yields while curtailing excess consumption.

Minimize Measurement Costs: Installing a gas flow measurement device or system will impose certain costs including equipment purchase and installation and meter calibration and maintenance.

Pharmaceutical Mass Flow Controller Market Geographical Analysis

North America is expected to hold the largest share of about 6.4% in the global pharmaceutical mass flow controller market in 2019, owing to the increasing implementation of these controllers in pharmaceutical industries.

North America pharmaceutical mass flow controller and is estimated to grow at a CAGR of 6.5% during the forecast period (2023-2030).  As of 2019, there are more than 800 active Investigational New Drug (IND) waiting for approval with the FDA. These burgeoning approvals and drug-developing pipelines are expected to promise more opportunities to the market. Apart from this, the US Government has increased the overall healthcare expenditure propelling the market growth. Pharmaceutical manufacturers have increased their investments in R&D for the development of better-quality mass flow controllers since it has a direct effect on the safety and efficacy of the drug.

For instance, ventilation devices used during emergency treatment are required for providing an optimum flow of oxygen to the ailing patient. In this case, the performance capability of mass flow controllers is crucial.

The United States healthcare spending is expected to have a 0.8% faster growth than the gross domestic product (GDP) per year over the 2018-27 period. The health share of GDP would rise from 17.9% in 2017 to 19.4% by 2027, as per estimates from the Centers for Medicare & Medicaid Services. The stricter regulation in the country ensures superior quality of the manufacturing and the end-product that is being adhered to by the CMOS.

Pharmaceutical Mass Flow Controller Companies and Competitive Landscape

The pharmaceutical mass flow controller is a fragmented market with the presence of a large number of market players. The key players operating in the pharmaceuticals mass flow controller market include Azbil Corporation, Brooks Instrument, Bronkhorst, Burkert, Sierra Instrument, Vogtlin, Tokyo Keiso, and Teledyne Hastings, Alicat Scientific, and Parker Hannifin.

These companies are launching new innovative solutions with advanced technologies. They are focused on providing efficient products to consumer industries to gain a competitive edge.

The key market players are adopting various strategies such as mergers and acquisitions, product approvals, and agreements to increase product reach and strengthen their product portfolios, to enter or expand their business offerings and competitiveness in the pharmaceutical mass flow controller market. For instance, In December 2020, Brooks Instrument added the GT1600 Series of glass tube variable area flow meters to its industry-leading family of variable area flow meter products. Suitable for a wide variety of industries from chemical manufacturing to pharmaceutical production to water treatment and distribution, the GT1600 is ideal for low- and high-flow gas and liquid applications where viewing the process is important. In October 2019, MKS Instruments launched next-generation C-series mass flow controllers, which use Micro-Electromechanical Systems (MEMS) technology combined with a fast-acting control valve and MKS proprietary algorithms resulting in an ultra-fast control time of fewer than 100 milliseconds.

Recent Developments:

  1. In July 2019, Brooks Instrument (US) launched two new mass flow controllers- the SLA5800 Series Biotech and the SLAMf series Biotech designed for biotechnology applications.
  2. In January 2019, Bronkhorst High-Tech (Netherlands) launched the IN-FLOW series of mass flow meters and controllers featuring a rugged, IP65-rated dustproof and waterproof design. Available for flow ranges from 0.05–1 mln/min up to 200–10000 m³n/h air-equivalent, the IN-FLOW series flow meters come with optional ATEX approval for use in Category 3, Zone 2 hazardous areas and are now offered with FM approval for Class I, Division 2 to meet the needs of the North American market.

Trending Topics

Gas Detection Equipment Market

Well Interventions Market

Shore Power Market

Buy this report
Single User
Multiple User
Enterprise User
Proceed to Buy
What is the Projected CAGR value of the Pharmaceutical Mass Flow Controller Market?
Pharmaceutical Mass Flow Controller Market is expected to reach a CAGR 6.4% during the forecast period (2023-2030).
Which region controlled the global market during 2023-2030?
North America region Controls the Pharmaceutical Mass Flow Controller Market during 2023-2030.
Which is the fastest growing region in the Pharmaceutical Mass Flow Controller Market?
Among all regions, Asia Pacific is the fastest growing market share during the forecast period.